Del. Justices Uphold $56M Award In Drug Contract Dispute
Delaware's Supreme Court late Monday upheld a $55.8 million breach of contract ruling from September 2017 that favored oncology drug developer Wellstat Therapeutics Corp., but called for revised prejudgment interest calculations...To view the full article, register now.
Already a subscriber? Click here to view full article